Chin Hyok Lee - Feb 9, 2024 Form 3 Insider Report for Allakos Inc. (ALLK)

Role
Chief Medical Officer
Signature
/s/ H. Baird Radford III, by power of attorney
Stock symbol
ALLK
Transactions as of
Feb 9, 2024
Transactions value $
$0
Form type
3
Date filed
2/16/2024, 07:08 PM
Next filing
Feb 21, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ALLK Common Stock 331K Feb 9, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ALLK Stock Option (Right to buy) Feb 9, 2024 Common Stock 420K $3.31 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares represented by restricted stock units ("RSU"). Each RSU represents the Reporting Person's right to receive one share of Common Stock of the Issuer subject to the applicable vesting schedule, subject to the Reporting Person continuing as a service provider through each such date.
F2 The option was granted on August 17, 2023. The option vests as to one-fourth of the shares on August 17, 2024, and one forty-eight of the shares vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.